The Pharmacy Market Review 2025 by Christie & Co gives a wide angle on how community pharmacy across the UK is evolving. While many of the pressures are shared across England, Scotland, Wales and Northern Ireland, there are particular dynamics in Northern Ireland that deserve closer attention. This article examines how the UK trends play out in the Northern Ireland context, and what local pharmacies should consider in the coming years.
Market Trends and Dispensing in Northern Ireland
Northern Ireland’s latest official statistics show the total number of community pharmacies stood at 508 in 2024 to 2025, down by three from the prior year. Community pharmacies handled over 99 percent of all prescription items during that period, with total item volume reaching 45.7 million, a one percent increase year on year. On average, each pharmacy dispensed more than 89,000 items, the highest level ever recorded.
Demand is rising, but Northern Ireland faces cost pressures, geographic variation, and challenges of rural access. While most residents live within a mile of a pharmacy, in rural districts such as Fermanagh and Omagh, average distance rises to around 1.6 miles. Across the rest of the UK, pharmacy numbers continue to fall, and independent ownership is increasing as large chains divest. These trends will inevitably influence Northern Ireland’s market structure.
Funding and Contractual Models
Northern Ireland operates under the Health and Social Care model rather than the NHS England contracts. That means changes in England’s Community Pharmacy Contractual Framework do not apply directly, but they set benchmarks and influence expectations across the UK.
The English sector’s 2025 to 2026 funding uplift highlights the real pressure on pharmacy finances across the UK. If funding in England rises, Northern Ireland stakeholders may seek similar investment to maintain parity and fairness for contractors. The Community Pharmacy Strategic Plan 2030 provides a roadmap for continued development under Health and Social Care, but its success will depend on funding that matches cost growth and service expansion.
Workforce, Locums, and Regional Challenges
The Christie and Co review emphasises sharp increases in staff costs, wage pressures, and locum volatility. Northern Ireland’s rural and border areas face additional difficulties including travel costs, professional isolation, recruitment challenges, and smaller labour pools. Average salary rises seen across the UK apply in Northern Ireland too, but they have a greater impact on small rural pharmacies.
To maintain resilience, pharmacies may need to invest in retention packages, flexible working, incentives for rural practice, and clear career paths for pharmacy technicians and support staff.
Expanding Clinical Services and Innovation
The UK review shows that future sustainability depends on expanding clinical services beyond dispensing. In Northern Ireland, there is strong momentum toward closer integration of pharmacy within general practice. The Department of Health has proposed building full pharmacy teams within GP practices, including pharmacists, technicians, and advanced practice roles, to lead medicines management and relieve GP workload.
Northern Ireland already operates a limited Pharmacy First model where pharmacists can treat common conditions without GP intervention. There are ongoing plans to expand its scope, improve referral pathways, and increase independent prescribing. Private and preventative services such as vaccinations, travel health, and weight management are also growing areas of opportunity.
Regulatory and Online Trends
In England, new restrictions on Distance Selling Pharmacies will take effect in mid 2025. Northern Ireland has not mirrored these changes yet, but the developments serve as useful case studies for balancing access, safety, and sustainability.
Post Brexit medicine labelling requirements also pose challenges. Northern Ireland pharmacies must use UK only labelled medicines, creating supply chain and cost implications. Contractors will need to stay alert to regulatory changes tied to UK and EU trade arrangements, especially in border regions and for online supply.
Sentiment, Investment, and Transactions
The UK pharmacy market remains active despite economic pressures. Many larger chains are divesting, creating openings for smaller operators and first time buyers. Given Northern Ireland’s smaller network, each transaction can have significant local impact.
Survey responses from across the UK show mixed sentiment. Pharmacists see increasing demand for clinical and private services but remain cautious about funding, regulation, and workload. This highlights the importance of long term planning and adaptable business models.
Conclusion
The Pharmacy Market Review 2025 shows that community pharmacy across the UK is under pressure but also full of opportunity. In Northern Ireland, rising prescription volumes, new service models, and regulatory complexity make strategic planning essential.
With sustained funding, workforce investment, and innovation, Northern Ireland can shape a forward looking pharmacy model that delivers accessible, high quality care and secures the future of community pharmacy for years to come.
Thanks to the team at Christie & Co as well as Locate A Locum for producing such a vital market update.
